Basal ganglia

Citations 1-10 of 32 total displayed.

Most recent content (21 Apr 2009):

EDITORIALS
A new sensitive imaging biomarker for Parkinson disease?

Anthony E. Lang and David Mikulis
Neurology 2009; 72: 1374-1375. [Full text] [PDF]  

ARTICLES
High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease

D. E. Vaillancourt, M. B. Spraker, J. Prodoehl, I. Abraham, D. M. Corcos, X. J. Zhou, C. L. Comella, and D. M. Little
Neurology 2009; 72: 1378-1384. [Abstract] [Full text] [PDF]  

ARTICLES
Striatal [¹¹C]dihydrotetrabenazine and [¹¹C]methylphenidate binding in Tourette syndrome

R. L. Albin, R. A. Koeppe, K. Wernette, W. Zhuang, T. Nichols, M. R. Kilbourn, and K. A. Frey
Neurology 2009; 72: 1390-1396. [Abstract] [Full text] [PDF]  

Past content (since Mar 2003):

ARTICLES
PET demonstrates reduced dopamine transporter expression in PD with dyskinesias

A. R. Troiano, R. de la Fuente-Fernandez, V. Sossi, M. Schulzer, E. Mak, T. J. Ruth, and A. J. Stoessl
Neurology 2009; 72: 1211-1216. [Abstract] [Full text] [PDF]  

RESIDENT AND FELLOW SECTION
Teaching NeuroImages: Face of the giant panda and her cub: MRI correlates of Wilson disease

R. Shivakumar and Sanjeev V. Thomas
Neurology 2009; 72: e50. [Full text] [PDF]  

EDITORIALS
Will tricyclic antidepressants make a comeback for depressed Parkinson disease patients?

Michael S. Okun and Hubert H. Fernandez
Neurology 2009; 72: 868-869. [Full text] [PDF]  

RESIDENT & FELLOW SECTION
Pearls & Oy-sters: Resolution of hemichorea following endarterectomy for severe carotid stenosis

I. Galea, F. Norwood, M. J. Phillips, C. Shearman, P. McMonagle, and W. R. Gibb
Neurology 2008; 71: e80-82e. [Full text] [PDF]  

CLINICAL/SCIENTIFIC NOTES
IN NEUROCYSTICERCOSIS, CSF CYTOKINES CORRELATE WITH CEREBRAL BLOOD FLOW VELOCITIES

Fernando Góngora-Rivera, José Luis Soto-Hernández, Patricia Guevara, and Julio Sotelo-Morales
Neurology 2008; 71: 1119-1122. [Full text] [PDF]  

EDITORIALS
Fine-tuning gait in Parkinson disease

Michele Tagliati
Neurology 2008; 71: 76-77. [Full text] [PDF]  

ARTICLES
A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease

M. Stacy, D. Silver, T. Mendis, J. Sutton, A. Mori, P. Chaikin, and N. M. Sussman
Neurology 2008; 70: 2233-2240. [Abstract] [Full text] [PDF]  

[Next page] Pages: 1 2 3 4